Healthscore 220·3 metrosupdated 3h ago
FDA Issues Recall for Subpotent Thyroid Medication
The FDA has announced a Class II recall of a thyroid medication, warning that it may lead to temporary health issues. Patients using the affected drug are advised to consult their healthcare providers.
Where it's breaking
Local coverage
Sources cited
Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.
What this is
A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.